Predictive biomarkers of survival after neoadjuvant chemotherapy for breast cancer

被引：0
|
作者：
Galvez-Nino, Marco [1 ]
Roque, Katia [1 ]
Angel Bernabe, Luis [1 ]
Castillo, Miluska [1 ]
Sanchez, Joselyn [1 ]
Landa Baella, Maria [1 ]
Calderon, Gabriela [1 ]
De la Cruz, Miguel [1 ]
Dunstan, Jorge [1 ]
Abugatas, Julio [1 ]
Cotrina, Jose [1 ]
Castaneda, Carlos [1 ]
Gomez, Henry [1 ]
机构：
[1] Inst Nacl Enfermedades Neoplas, Lima, Peru
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
Breast cancer; Neoadjuvant; Residual cancer burden; TILs; progression-free survival;
D O I：
10.1158/1538-7445.SABCS19-P1-10-22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-10-22
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Neoadjuvant Chemotherapy for Luminal Androgen Receptor (LAR) Breast Cancer: Potential Predictive Biomarkers and Genetic Alterations
    Li, Ming
    Lv, Hong
    Zhou, Shuling
    Lu, Hongfen
    Shui, Ruohong
    Cheng, Yufan
    Yu, Bao-Hua
    Bi, Rui
    Xu, Xiaoli
    Yang, Wentao
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S168 - S169
  • [32] Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer
    Thomae, Keith
    Sargent
    Russell, Christy A.
    Russell
    [J]. AMERICAN JOURNAL OF SURGERY, 2022, 223 (03): : 543 - 543
  • [33] Predictive factors of response to anthracylines neoadjuvant chemotherapy in breast cancer
    Bensouda, Y.
    Ismaili, N.
    Ahbeddou, N.
    El Hassani, K.
    Chenna, M.
    Sbitti, Y.
    Boutayeb, S.
    Errihani, H.
    [J]. GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2011, 39 (02): : 81 - 86
  • [34] PREDICTIVE SIGNIFICANCE OF BREAST CANCER SUBTYPES IN RESPONSE TO NEOADJUVANT CHEMOTHERAPY
    Kobayashi, N.
    Kiriyama, Y.
    Hikichi, M.
    Miyajima, S.
    Kuroda, M.
    Utsumi, T.
    [J]. BREAST, 2013, 22 : S103 - S103
  • [35] Insight or Confusion: Survival After Response-Guided Neoadjuvant Chemotherapy in Breast Cancer
    Telli, Melinda L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3613 - 3615
  • [36] PREDICTIVE FACTORS OF NO RESPONSE DURING NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER
    Jo, J.
    Yoo, C.
    Kim, J. -E.
    Ahn, J. -H.
    Kim, S. -B.
    Kim, H. -H.
    Cha, J. H.
    Shin, H. J.
    Ahn, S. -H.
    Son, B. H.
    Lee, J. W.
    Kim, H. J.
    Gong, G.
    Jung, K. H.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 40 - 40
  • [37] Assessment of Predictive Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
    Tewari, Mallika
    Pradhan, Satyajit
    Singh, Usha
    Singh, Taj Bali
    Shukla, Hari Shankar
    [J]. ASIAN JOURNAL OF SURGERY, 2010, 33 (04) : 157 - 167
  • [38] Receptor discordances in locally advanced breast cancer after neoadjuvant chemotherapy and their effects on survival
    Tural, Deniz
    Karaca, Mustafa
    Zirtiloglu, Alisan
    Hacioglu, Bekir M.
    Sendur, Mehmet A. N.
    Ozet, Ahmet
    [J]. JOURNAL OF BUON, 2019, 24 (01): : 20 - 25
  • [39] Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer
    Woo, Jinsun
    Ryu, Jai Min
    Jung, Sung Mi
    Choi, Hee Jun
    Lee, Se Kyung
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Chae, Byung Joo
    [J]. EJSO, 2021, 47 (02): : 232 - 239
  • [40] Bladder Cancer Survival Times after neoadjuvant Chemotherapy
    Gakis, Georgios
    [J]. AKTUELLE UROLOGIE, 2016, 47 (06) : 439 - U67
12345